AI assistant
Ajooni Biotech Limited — Call Transcript 2024
May 21, 2024
62322_rns_2024-05-21_0c46ad27-862d-4c1d-8221-caacc6561072.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [97 x 82] intentionally omitted <==
AJOONI BIOTECH LIMITED
Regd. Office: D-118, Industrial Area, Phase VII, Mohali-160055 (Pb.) Phone: 0172-5020758-69 Website: www.ajoonibiotech.com E-mail: [email protected] / [email protected]
CIN: L85190PB2010PLC040162
Date:-21/05/2024
To The Secretary National Stock Exchange of India Limited Exchange Plaza, BandraKurla Complex Bandra (East), Mumbai - 400051
Sub : Intimation of Schedule of Conference Call for Q4FY24 and FY24 | Ajooni Biotech Limited(“the Company”)
Ref : Information under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”) of Conference Call with analyst(s)/institutional investor(s)
Dear Sir/ Madam,
Pursuant to Regulation 30(6) of the Listing Regulations, we would like to inform you that the Conference Call to discuss the Company’s results and performance outlook post the declaration of its Q4FY24 and FY24 results has been scheduled on Thursday, May 23, 2024 at 12.15 P.M. IST, subject to the approval and announcement of financial results of the Company for the quarter and financial year ended on March 31, 2024.
The details of the aforesaid investor/analyst conference call and registration link are enclosed herewith. The same will also be hosted on the website of the Company at www.ajoonibiotech.com.
We request you to kindly take the aforesaid information on record and disseminate the same on your respective websites.
Thanking You, Yours Truly, For Ajooni Biotech Limited
JASJOT Digitally signed by JASJOT SINGH SINGH Date: 2024.05.21 17:02:21 +05'30' Jasjot Singh Managing Director DIN: 01937631
________________
Works: G.T. Road, Khanna- 141401 (Punjab) INDIA
Earnings Conference Call Invite
==> picture [182 x 203] intentionally omitted <==
==> picture [77 x 88] intentionally omitted <==
==> picture [78 x 88] intentionally omitted <==
==> picture [55 x 54] intentionally omitted <==
Thursday, May 23, 2024 12:15 PM
Kirin Advisors Cordially invite you to the Q4 FY24 Earnings Call of Ajooni Biotech Limited
==> picture [158 x 192] intentionally omitted <==
==> picture [77 x 64] intentionally omitted <==
==> picture [55 x 66] intentionally omitted <==
Joining Details Universal Dial In International Toll-Free Numbers Diamond Pass Login +91 22 6280 1239 USA : 18667462133 +91 22 7115 8140 UK : 08081011573 Click Here To Register Singapore : 8001012045 Hong Kong : 800964448
Note - When using dial-in numbers mentioned above please do so 10 minutes prior to the conference schedule to ensure that you are connected to your call in time.
==> picture [96 x 160] intentionally omitted <==
Speakers From Management
Mr. Jasjot Singh – MD & CFO Mr. Gurmeet Singh Bhatia - Chairman Ms. Swati Vijan - Company Secretary
==> picture [94 x 189] intentionally omitted <==
For More Information
==> picture [102 x 73] intentionally omitted <==
+91 22 4100 2455 [email protected] 713-B Lodha Supremus II, Wagle www.kirinadvisors.com +91 93244 75886 [email protected] Estate, Thane (W) 400 604.
Disclaimer - Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and abroad. Actual results might differ substantially from those expressed or implied. The company and its Management will not be in any way responsible for any action taken based on such statements and discussions.